The New England Journal of Medicine

Platelet Aggregation in Patients with Laennec's Cirrhosis of the Liver

Proteolytic degradation products of fibrinogen, produced as a result of excessive fibrinolysis, have been demonstrated in the blood of cirrhotic patients. 7,8 Such degradation products, when formed in ...
Nature

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Bleeding because of impaired platelet function is a major side effect of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation ...
Nature

BROAD SPECTRUM ANTI-PLATELET AGGREGATION THERAPY IMPROVES POSTISCHEMIC CEREBRAL BLOOD FLOW (CBF) AND CORTICAL SOMATOSENSORY EVOKED RESPONSE ...

Previously we showed that platelets accumulate in areas of low CBF 4h after brain ischemia. Similarly, CSER and CBF recovery after brain ischemia was enhanced in dogs treated with either prostacyclin ...
The New England Journal of Medicine

Platelet Dysfunction — Differentiation of a Newly Recognized Primary Type from That Produced by Aspirin

A recently described hemorrhagic disorder characterized by defective platelet aggregation induced by collagen and epinephrine appears to be caused, in part, by the same abnormality induced by aspirin ...
TCTMD

Platelet Reactivity in Response to Prasugrel Depends on the Test

LOS ANGELES, CA—In patients with acute coronary syndromes (ACS) treated with prasugrel, the incidence of high on-treatment platelet reactivity depends on the type of platelet function test used, ...